drugset / Trial / NCT00442741

Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)

NCT00442741

Phase 1 Withdrawn Novartis Pharmaceuticals
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this extension study is to evaluate the potential inhibitory effects of patupilone on metabolism using midazolam and omeprazole as the respective probe drugs.

Timeline

Start
2007-07
Primary completion
2007-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified
Subject Patupilone Small molecule

Indications